drugset / Trial / NCT03669133
Vitamin E for NASH Treatment in HIV Infected Individuals
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to see how taking Vitamin E daily affects fatty liver in persons living with HIV. Subjects will have both HIV and a fatty liver and the purpose of the study is to learn if underlying liver condition (fatty liver) gets better, worse, or stays the same from taking Vitamin E.
Timeline
- Start
- 2019-10-01
- Primary completion
- 2021-03-08
- Completion
- 2021-03-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vitamin E | Other / unclassified | 800 iu | — |